Impacts of Artificial Intelligence on the Development of Medical Products

Event description

Presenter: Diane Earp, MSHS, SBB(ASCP)

In this webinar, Diane Earp Vice President, Corporate Regulatory Compliance, at Research Triangle Institute, will discuss the evolving capabilities of Artificial Intelligence (AI) in MedTech development including its impact on clinical trials, new medical devices, drug efficacy, pharmacovigilance, and robotics. This presentation is developed for innovators engaged in product development and seeks to provide considerations and potential implications of the rise of AI on your development, manufacturing, and regulatory process. Time will be allotted for questions and answers.

Presenter Diane Earp has over 25 years of experience working in regulatory affairs and quality assurance with expertise in U.S. and international regulatory requirements applicable to drug, biologics, and medical device development, testing/validation, manufacturing, and distribution.

Webinar presented on May 17, 2023 to an invited audience.

This video is provided for educational purposes only.

Download slides
This research was, in part, funded by the National Institutes of Health (NIH) Agreement OT2 HL157844-01. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the NIH.